Correlation Between Merrimack Pharmaceuticals and Graphite Bio
Can any of the company-specific risk be diversified away by investing in both Merrimack Pharmaceuticals and Graphite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merrimack Pharmaceuticals and Graphite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merrimack Pharmaceuticals and Graphite Bio, you can compare the effects of market volatilities on Merrimack Pharmaceuticals and Graphite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merrimack Pharmaceuticals with a short position of Graphite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merrimack Pharmaceuticals and Graphite Bio.
Diversification Opportunities for Merrimack Pharmaceuticals and Graphite Bio
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Merrimack and Graphite is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Merrimack Pharmaceuticals and Graphite Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Graphite Bio and Merrimack Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merrimack Pharmaceuticals are associated (or correlated) with Graphite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Graphite Bio has no effect on the direction of Merrimack Pharmaceuticals i.e., Merrimack Pharmaceuticals and Graphite Bio go up and down completely randomly.
Pair Corralation between Merrimack Pharmaceuticals and Graphite Bio
If you would invest (100.00) in Graphite Bio on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Graphite Bio or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Merrimack Pharmaceuticals vs. Graphite Bio
Performance |
Timeline |
Merrimack Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Graphite Bio |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Merrimack Pharmaceuticals and Graphite Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merrimack Pharmaceuticals and Graphite Bio
The main advantage of trading using opposite Merrimack Pharmaceuticals and Graphite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merrimack Pharmaceuticals position performs unexpectedly, Graphite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Graphite Bio will offset losses from the drop in Graphite Bio's long position.Merrimack Pharmaceuticals vs. Amicus Therapeutics | Merrimack Pharmaceuticals vs. Celldex Therapeutics | Merrimack Pharmaceuticals vs. Puma Biotechnology | Merrimack Pharmaceuticals vs. Agios Pharm |
Graphite Bio vs. Assembly Biosciences | Graphite Bio vs. Instil Bio | Graphite Bio vs. Nuvation Bio | Graphite Bio vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |